Format

Send to

Choose Destination
J Ethnopharmacol. 2019 May 10;235:122-132. doi: 10.1016/j.jep.2019.02.008. Epub 2019 Feb 6.

The antifungal and Cryptococcus neoformans virulence attenuating activity of Pelargonium sidoides extracts.

Author information

1
Department of Microbiology, Stellenbosch University, Private Bag X1, Stellenbosch 7602, South Africa. Electronic address: 18357571@sun.ac.za.
2
Department of Microbiology, Stellenbosch University, Private Bag X1, Stellenbosch 7602, South Africa. Electronic address: kim@sun.ac.za.
3
Department of Microbiology, Stellenbosch University, Private Bag X1, Stellenbosch 7602, South Africa; Central Analytical Facility, Stellenbosch University, Private Bag X1, Stellenbosch 7602, South Africa. Electronic address: lydiaj@sun.ac.za.
4
Department of Botany and Zoology, Stellenbosch University, Private Bag X1, Stellenbosch 7602, South Africa. Electronic address: makunga@sun.ac.za.
5
Department of Microbiology, Stellenbosch University, Private Bag X1, Stellenbosch 7602, South Africa. Electronic address: volschenkh@sun.ac.za.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE:

Limitations of clinical antifungal treatments and drug-resistance are drivers of the search for novel antifungal strategies. Extracts prepared from the tubers of the medicinal plant, Pelargonium sidoides, are known for their antiviral and antibacterial activities and are used in ethnomedicine for the treatment of acute respiratory infections. Their impact on fungi has not been well characterised. Here, we provide a first report on the antifungal activity of a P. sidoides aerial tissue extract against Cryptococcus neoformans as well as the effects of both tuber and aerial tissue extracts on selected virulence factors.

AIM OF THE STUDY:

Novel antimicrobial strategies that target multiple cellular pathways or make use of anti-pathogenic compounds that inhibit virulence factors have been proposed. This work aimed to evaluate P. sidoides plant parts for their anticryptococcal activity and antipathogenic properties on selected virulence factors.

MATERIALS AND METHODS:

The antifungal activity of crude P. sidoides tuber and aerial tissue extracts (15% m/m ethanol) were compared using a modified colourimetric antifungal susceptibility test. Fungicidal activity of the extracts was confirmed by plate counts. To test yeast resistance to the extracts, it was conditioned by multiple passages in sub-lethal doses followed by antifungal susceptibility testing. Cytotoxicity of the extracts was tested with a blood agar haemolysis assay. Extracts were evaluated for the presence of multiple bioactive compounds by solid-phase fractionation and visualisation by thin-layer chromatography in combination with bioassays. The influence of extracts on the production of the polysaccharide capsule, ergosterol content as well as laccase and urease activities were also evaluated. Cell surface variations after extract exposure were visualised by scanning electron microscopy (SEM).

RESULTS:

Both tuber and aerial tissue extracts were fungicidal and contained multiple bioactive compounds which constrained the development of antifungal resistance. No haemolytic activity was observed, and the extracts did not appear to target ergosterol biosynthesis. However, the extracts displayed anti-pathogenic potential by significantly inhibiting laccase and urease activity while also significantly reducing capsule size. SEM revealed notable cell surface variations and provided support for the observed reduction in capsule size.

CONCLUSIONS:

Our results provide support to the exploration of medicinal plants as sources of alternative antifungal therapies and the potential use of multicomponent inhibition and or virulence attenuation for next-generation treatment strategies. Our data also provide relevant information that may support the further use of P. sidoides in traditional medicines as well as in commercialised phytopharmaceuticals.

KEYWORDS:

Anti-pathogenic; Antifungal; Cryptococcus neoformans; Pelargonium sidoides; Traditional medicine; Virulence factors

PMID:
30738119
DOI:
10.1016/j.jep.2019.02.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center